Clinical Research Collaborations
- Development of new treatments: NIH and industry collaborations with global pharmaceutical and biotechnology companies.
- Identification of biological markers: Collaborations with researchers at other medical schools and universities to develop reliable blood tests for diagnosing AD.
- Neuroimaging initiative: a multi-center NIH project to refine the use of structural and functional neuroimaging studies, along with potential biomarkers in blood, spinal fluid, and urine samples, in order to better diagnose AD and to potentially follow response to therapies.
- Diagnosis and differential diagnosis of MCI and AD: data from our database contribute to several investigations with other medical schools and universities on the use of psychometric tests for diagnosing MCI and AD.
- Identification of risk factors for the development of AD: data from our normal control project and patient database are used in several studies seeking to identify such risk factors.
- Analysis of multi-center clinical trials databases: with others, we seek a better understanding of the benefits and limitations of current therapies and drugs under development for treating AD and other forms of dementia.
- Examining how well both patients with dementia and those who do not have dementia recognize their depression.
- Online survey of lay caregivers of patients with Alzheimer's disease examining individual caregiver's communication skills, social network support, and perceived coping.